Inside Precision Medicine August 2, 2024
IPM Staff

The BePRECISE consortium has published guidelines aimed at improving the accuracy, safety, and health equity in precision medicine. These are all critical issues in the field that have been largely overlooked. The paper appears in Nature Medicine and the lead author is Siew S. Lim, of Health Systems and Equity at Monash University.

Diversity in particular has been hard to address: In 2021, researchers estimated the proportion of samples from individuals of European ancestry they included in genome-wide association studies (GWAS) was 86.3 percent.

BePRECISE stands for “Better Precision-data Reporting of Evidence from Clinical Intervention Studies & Epidemiology.” It comprises a group of experts based in low-, middle- and high-income countries dedicated to improving the reporting standards of precision medicine...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Precision Medicine
A New Era of Healthcare: Patient Monitoring Meets Precision Medicine
Exploring the potential of personalized precision medicine for healthcare industry
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care

Share This Article